FIELD: medicine.
SUBSTANCE: invention refers to medicine. Streptomycin processed by 0.15±0.05 % formalin at 40.0±2.0°C for 5-7 days is administered to an animal, in daily dose 25 mg/kg of animal's body weight intramuscularly for 16 days.
EFFECT: use of the method provides higher survival rate and reduces length of treatment.
1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INCREASING ACTIVITY OF STREPTOMYCIN ANTIBIOTIC TOWARDS STREPTOMYCIN-RESISTANT M TUBERCULOSIS | 2009 |
|
RU2405834C1 |
| COFORMULATED ANTITUBERCULOUS DRUG | 2009 |
|
RU2430724C2 |
| PROBIOTIC BACTERIAL PREPARATION OF CORPUSCULAR ANTIGENS OF LIPOPEPTIDOPOLYSACCHARIDE CORYNEBACTERIA FOR PREVENTION AND TREATMENT OF TUBERCULOSIS, METHOD FOR PREPARING IT | 2011 |
|
RU2468816C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2009 |
|
RU2413517C1 |
| METHOD FOR ENSURING HIGHER EFFICACY OF STREPTOMYCIN WITH RESPECT TO STREPTOMYCIN-RESISTANT TUBERCULOSIS MYCOBACTERIA | 2010 |
|
RU2426790C1 |
| COMBINED ANTITUBERCULOUS COMPOSITION | 2010 |
|
RU2468802C2 |
| RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| METHOD OF PREDICTING INCREASE OF VOLUME OF PULMONARY TISSUE INJURY AT INFILTRATIVE TUBERCULOSIS | 2016 |
|
RU2633077C1 |
| METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
